calpeptin has been researched along with telaprevir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chia, CSB; Fong, JY; Guo, X; Joy, J; Karuna, R; Liu, B; See, YY; Tan, LH; Tan, QW; Tan, ST; Vankadara, S; Wang, G; Wong, YX | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for calpeptin and telaprevir
| Article | Year |
|---|---|
A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Cysteine Proteinase Inhibitors; Enzyme Assays; Fluorescence Resonance Energy Transfer; Inhibitory Concentration 50; Peptidomimetics; Protein Binding; SARS-CoV-2 | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |